New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
07:35 EDTSTEMStemCells announces first patient cohort completes spinal cord injury trial
StemCells announced that the twelve-month data from the first patient cohort in the company's Phase I/II clinical trial of its proprietary HuCNS-SC product candidate, or purified human neural stem cells, for chronic spinal cord injury continued to demonstrate a favorable safety profile, and showed that the considerable gains in sensory function observed in two of the three patients at the six-month assessment have persisted. The third patient remains stable.
News For STEM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 18, 2014
08:06 EDTSTEMStemCells transplants first participant in Phase II clinical trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use